Literature DB >> 25757160

Enhancement of the TCRζ expression, polyclonal expansion, and activation of t cells from patients with acute myeloid leukemia after IL-2, IL-7, and IL-12 induction.

Li Shi1, Shaohua Chen1, Xianfeng Zha2, Yan Xu1,3, Ling Xu1, Lijian Yang1, Yuhong Lu4, Kanger Zhu4, Yangqiu Li1,3.   

Abstract

Defective T cell receptor (TCR) signaling resulting in lower T cell function plays a crucial role in the pathogenesis of T cell immunodeficiency in leukemia. Previous studies have indicated that lower TCRζ levels are a common characteristic of patients with leukemia, and upregulating TCRζ could partially recover T cell function. In this study, we characterized the effect of the stimulating factor induction on the TCRζ, Zap-70, and FcɛRIγ levels, IFN-γ secretion, and the distribution and clonal expansion of TCR Vβ subfamilies in CD3(+) T cells sorted from peripheral blood from acute myeloid leukemia (AML) patients. The induction included single stimulating factor or a combination with different cytokines (IL-2, IL-7, IL-2+IL-7, IL-7+IL-12, CD3, CD3+CD28 antibody, CD3+CD28 antibody+IL-2, and CD3+CD28 antibody+IL-7) at 72 h. The results showed that increased TCRζ and Zap-70 levels with deceased FcɛRIγ in T cells after induction, and different responses to cytokine in T cell from different cases may indicate the heterogeneity of T cells and different immune statuses in different AML cases. Increased IFN-γ levels in T cells from AML patients were detected after induction in the IL-12+IL-7, CD3+CD28+IL-2, and CD3+CD28+IL-7 groups. Moreover, the number of TCR Vβ subfamily T cells expressed was increased; however, all of the TCR Vβ subfamily T cells in the AML patients could not be completely recovered after induction. In conclusion, the cytotoxicity and activation function of T cells could be enhanced after induction by different stimuli accompanied by an increase in TCRζ and Zap-70 and recovery of the TCR Vβ repertoire in AML patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25757160      PMCID: PMC4504257          DOI: 10.1089/dna.2015.2810

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  34 in total

1.  The T-cell receptor Vbeta gene repertoire and clonal expansion from peripheral blood T cells in benzene-exposed workers in China.

Authors:  Bo Li; Yangqiu Li; Shaohua Chen; Lijian Yang; Wei Yu; Jiayu Chen; Weiwei Liu
Journal:  Hematology       Date:  2009-04       Impact factor: 2.269

2.  Gene expression profiling of CD3gamma, delta, epsilon, and zeta chains in CD4(+) and CD8(+) T cells from human umbilical cord blood.

Authors:  Shaohua Chen; Lijian Yang; Xiaoye Lu; Bo Li; John Yeuk-Hon Chan; Dongqing Cai; Yangqiu Li
Journal:  Hematology       Date:  2010-08       Impact factor: 2.269

3.  The TCR Vbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen.

Authors:  Yangqiu Li; Lijian Yang; Shaohua Chen; Yuping Zhang; Xiuli Wu
Journal:  Hematology       Date:  2005-10       Impact factor: 2.269

4.  Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients.

Authors:  Shaohua Chen; Xianfeng Zha; Lijian Yang; Bo Li; Zhong Liye; Yangqiu Li
Journal:  Hematology       Date:  2011-01       Impact factor: 2.269

Review 5.  CD3 deficiencies.

Authors:  Alain Fischer; Geneviève de Saint Basile; Françoise Le Deist
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-12

6.  TCR zeta chain expression in T cells from patients with CML.

Authors:  Si Chen; Lijian Yang; Shaohua Chen; Yangqiu Li
Journal:  Hematology       Date:  2009-04       Impact factor: 2.269

7.  Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases.

Authors:  Yangqiu Li
Journal:  Hematology       Date:  2008-10       Impact factor: 2.269

Review 8.  Prognostic factors in elderly patients with AML and the implications for treatment.

Authors:  Harry P Erba
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

9.  Reduced levels of recent thymic emigrants in acute myeloid leukemia patients.

Authors:  Yangqiu Li; Qingsong Yin; Lijian Yang; Shaohua Chen; Suxia Geng; Xiuli Wu; Liye Zhong; Christian A Schmidt; Grzegorz K Przybylski
Journal:  Cancer Immunol Immunother       Date:  2008-11-19       Impact factor: 6.968

Review 10.  Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells.

Authors:  Jochen Greiner; Lars Bullinger; Barbara-ann Guinn; Hartmut Döhner; Michael Schmitt
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

View more
  8 in total

1.  CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.

Authors:  Zhen Yu; Dong Li; Xiu-li Ju
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-21       Impact factor: 4.553

2.  Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia.

Authors:  Jiaxiong Tan; Shaohua Chen; Yuhong Lu; Danlin Yao; Ling Xu; Yikai Zhang; Lijian Yang; Jie Chen; Jing Lai; Zhi Yu; Kanger Zhu; Yangqiu Li
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

3.  Upregulated TCRζ improves cytokine secretion in T cells from patients with AML.

Authors:  Shaohua Chen; Xianfeng Zha; Li Shi; Lingling Zhou; Lijian Yang; Bo Li; Xiuli Wu; Jun Zhong; Tao Zhang; Yuhong Lu; Kanger Zhu; Yangqiu Li
Journal:  J Hematol Oncol       Date:  2015-06-18       Impact factor: 17.388

Review 4.  The roles of stem cell memory T cells in hematological malignancies.

Authors:  Ling Xu; Yikai Zhang; Gengxin Luo; Yangqiu Li
Journal:  J Hematol Oncol       Date:  2015-10-14       Impact factor: 17.388

5.  Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI.

Authors:  Ling Xu; Jianyu Weng; Xin Huang; Chengwu Zeng; Shaohua Chen; Suxia Geng; Lijian Yang; Suijing Wu; Suming Huang; Xin Du; Yangqiu Li
Journal:  Oncotarget       Date:  2016-07-12

6.  Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer.

Authors:  Zhenjiang Liu; Thomas Poiret; Qingda Meng; Martin Rao; Anna von Landenberg; Esther Schoutrop; Davide Valentini; Ernest Dodoo; Inti Peredo-Harvey; Markus Maeurer
Journal:  J Transl Med       Date:  2018-07-03       Impact factor: 5.531

7.  High TRGV 9 Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid Leukemia.

Authors:  Xueting Kong; Jiamian Zheng; Xiaxin Liu; Wandi Wang; Xuan Jiang; Jie Chen; Jing Lai; Zhenyi Jin; Xiuli Wu
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

8.  Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation.

Authors:  Malwina Rybicka-Ramos; Mirosław Markiewicz; Aleksandra Suszka-Świtek; Ryszard Wiaderkiewicz; Sylwia Mizia; Monika Dzierżak-Mietła; Krzysztof Białas
Journal:  World J Biol Chem       Date:  2022-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.